EXPERT REACTION: AstraZeneca COVID-19 vaccine efficacy questioned
Not peer-reviewed: This work has not been scrutinised by independent experts, or the story does not contain research data to review (for example an opinion piece). If you are reporting on research that has yet to go through peer-review (eg. conference abstracts and preprints) be aware that the findings can change during the peer review process.
The US National Institute of Allergy and Infectious Diseases (NIAID) has released a statement suggesting AstraZeneca may have included outdated information in the trial of its COVID-19 vaccine, which may have provided an incomplete view of the efficacy data. AstraZeneca has released a response to the NIAID statement here. Below, Australian experts respond to the report.
Organisation/s: Australian Science Media Centre
Funder: N/A
News for:
Australia
NSW
VIC
QLD
Media contact details for this story are only visible to registered journalists.
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.